Subhodeep Sarker, Ph.D.
Affiliations: | University of Sydney, Camperdown, New South Wales, Australia |
Area:
Molecular Pharmacology and Toxicology, Experimental TherapeuticsWebsite:
https://sites.google.com/site/subhodeepsarker1/Google:
"Subhodeep Sarker"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Michael Freissmuth | grad student | 2007-2010 | Medical University of Vienna, Austria |
| Sudha K. Shenoy | post-doc | 2011-2012 | Duke |
| Mansour El-Matbouli | post-doc | 2013-2017 | University of Veterinary Medicine, Vienna |
| Renae Monique Ryan | post-doc | 2017-2019 | University of Sydney |
| Robert J. Vandenberg | post-doc | 2017-2019 | University of Sydney |
Collaborators
Sign in to add collaborator| Christopher L. Cioffi | collaborator | 2018- | Albany College of Pharmacy and Health Sciences (Chemistry Tree) |
| Gerhard F. Ecker | collaborator | 2007-2010 | University of Vienna |
| Harald H. Sitte | collaborator | 2007-2010 | Medical University of Vienna, Austria |
| Kunhong Xiao | collaborator | 2011-2012 | Duke Medical School |
| MacDonald J. Christie | collaborator | 2017-2019 | University of Sydney |
| Megan L. O'Mara | collaborator | 2017-2019 | ANU |
| Tristan Rawling | collaborator | 2017-2019 | University of Technology, Sydney (UTS) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mostyn SN, Sarker S, Muthuraman P, et al. (2020) A photoswitchable ORG25543 congener enables optical control of glycine transporter 2. Acs Chemical Neuroscience |
| Mostyn SN, Rawling T, Mohammadi S, et al. (2019) Development of an N-Acyl Amino Acid That Selectively Inhibits the Glycine Transporter 2 To Produce Analgesia in a Rat Model of Chronic Pain. Journal of Medicinal Chemistry. 62: 2466-2484 |
| Mostyn SN, Rawling T, Mohammadi S, et al. (2019) Development of an N-acyl amino acid that selectively inhibits the glycine transporter 2 to produce analgesia in a rat model of chronic pain. Journal of Medicinal Chemistry |
| Sarker S, Menanteau-Ledouble S, Kotob MH, et al. (2017) A RNAi-based therapeutic proof of concept targets salmonid whirling disease in vivo. Plos One. 12: e0178687 |
| Sarker S, El-Matbouli M. (2015) Can RNAi Target Salmonid Whirling Disease In Vivo? Nucleic Acid Therapeutics. 25: 285-6 |
| Sarker S, Kallert DM, Hedrick RP, et al. (2015) Whirling disease revisited: pathogenesis, parasite biology and disease intervention. Diseases of Aquatic Organisms. 114: 155-75 |
| Hasenhuetl PS, Schicker K, Koenig X, et al. (2015) Ligand Selectivity among the Dopamine and Serotonin Transporters Specified by the Forward Binding Reaction. Molecular Pharmacology. 88: 12-8 |
| Kumar G, Sarker S, Menanteau-Ledouble S, et al. (2015) Tetracapsuloides bryosalmonae infection affects the expression of genes involved in cellular signal transduction and iron metabolism in the kidney of the brown trout Salmo trutta. Parasitology Research. 114: 2301-8 |
| Sarker S, Xiao K, Shenoy SK. (2011) A tale of two sites: How ubiquitination of a G protein-coupled receptor is coupled to its lysosomal trafficking from distinct receptor domains. Communicative & Integrative Biology. 4: 528-31 |
| Sucic S, El-Kasaby A, Kudlacek O, et al. (2011) The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C. The Journal of Biological Chemistry. 286: 16482-90 |